Concepedia

Ago Ahene

AA

7

Publications

210

Citations

7

H-Index

2002

Active since

Affiliations

XOMA (United States)(Current)

Five Prime Therapeutics (United States)

The University of Texas MD Anderson Cancer Center

Amgen (United States)

Ago Ahene is an author at XOMA (United States) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

2002–2021

7

Publications

7

Safety and Pharmacokinetics of XOMA 3AB, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin A

Seema Nayak, J. McLeod Griffiss, R. McKenzie et al. · Antimicrobial Agents and Chemotherapy · 2014 · 61 citations · Full text

Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer

Hong Xiang, Abigael G. Chan, Ago Ahene et al. · mAbs · 2021 · 43 citations · Full text

, , +18

Cellular and Molecular Events Associated with the Bone-Protecting Activity of the Noncalcemic Vitamin D Analog Ro-26-9228 in Osteopenic Rats

Sara Peleg, Milan R. Uskoković, Ago Ahene et al. · Endocrinology · 2002 · 42 citations · Full text

Effect of Cellular Environment on the Selective Activation of the Vitamin D Receptor by 1α,25-Dihydroxyvitamin D<sub>3</sub>and Its Analog 1α-Fluoro-16-Ene-20-Epi-23-Ene-26,27-Bishomo-25-Hydroxyvitamin D<sub>3</sub>(Ro-26-9228)

Ayesha Ismail, Cuong V. Nguyen, Ago Ahene et al. · Molecular Endocrinology · 2004 · 26 citations · Full text

A Novel Allosteric Insulin Receptor–Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys

Padma Bezwada, Jingsong Zhao, Bob Shimizu et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 14 citations · Full text

Rows per page

1–5 of 7